Toxic to children if consumed orally or applied in large amounts to skin
This product used for the eyes has no drug interactions or documented toxicities
High doses of this product may put patients at risk for thiamine deficiency, especially in alcoholic patients.
The disodium form of this product can cause fatal hypocalcemia
Do not use this product if patient is taking other medications that affect serotonin levels.
This product has all the risks and benefits of caffeine stimulants
Avoid this product if the patient is immunocompromised and should be separated from oral antibiotics by 2 hours before or after
This "anti-aging" product should be used with caution with all medications that are metabolized by all major CYP enzymes
This product with strong scientific evidence supporting the use of it for chronic venous insuficiency should be used with caution in patients with blood pressure disorders and those taking NSAIDs, or anti-platelet agents.
Similar to aspirin and can cause Reye's syndrome when given to children with flu-like symptoms
This product should be avoided in patients with a history of fertility problems
Oral medications should be taken at least 2 hours before or 2 hours after a dose of this product to prevent decreased absorption of oral medication - especially if using powder dosage form
Prolonged use or high doses of this leaf can lead to muscle spasms, anemia and death
Some forms of this product can contain sulfites which can cause asthma problems
This product is contraindicated in immune diseases and contraindicated in pregnant patients because it has abortifacient properties
This product may interfere with MRI oral contrast agents.
This product is unsafe in patients with gallstones and/or biliary obstructions.
This product can lead to absinthism characterized by thirst, vertigo, and limb numbness
This product is banned from NCAA and is associated with increased risk of formaldehyde production
This product may cause thyroid hormone production stimulation and alter thyroid function
Avoid this product in female patients with hormone sensitive cancers, uterine fibroids, and endometriosis